AHS
EMN icon

Aspiriant Holdings S3’s Eastman Chemical EMN Stock Holding History

Aspiriant Holdings S3’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,364
Closed -$206K – 111
2014
Q2 		$206K Hold
2,364
– – 0.08% 113
2014
Q1 		$204K Buy
+2,364
New +$194K 0.09% 109

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aspiriant Holdings S3's EMN Position: Q3 2014 in Review

Aspiriant Holdings S3 sold out of Eastman Chemical (EMN) in Q3 2014, closing a stake of 2,364 shares — an estimated $206K sold.

Aspiriant Holdings S3 first reported a position in EMN in Q1 2014 and held it in 2 quarters. The position peaked at $206K in Q2 2014. 533 funds tracked by Wall St. Rank hold EMN as of Q3 2014.

  • Aspiriant Holdings S3 reported no remaining Eastman Chemical position as of Q3 2014 after selling out during the quarter.
  • Aspiriant Holdings S3 sold 2,364 Eastman Chemical shares in Q3 2014, an estimated $206K.
  • Aspiriant Holdings S3 first reported a position in Eastman Chemical in Q1 2014 and held it in 2 quarters.
  • Aspiriant Holdings S3's Eastman Chemical position peaked at $206K in Q2 2014.
  • 533 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2014.

Based on Aspiriant Holdings S3's 13F filing for Q3 2014, filed 28 Oct 2014.